BioAtla Inc (BCAB) Stock: 52-Week Performance Insights and Trading Volume

TOST Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BioAtla Inc’s current trading price is -83.90% away from its 52-week high, while its distance from the 52-week low is 69.42%. The stock’s price range for this period has been between $0.24 and $2.53 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.64 million for the day, a number notably higher than the average daily volume of 0.62 million over the last three months.

The stock of BioAtla Inc (BCAB) is currently priced at $0.41. In the last session, the stock climbed significantly, topping out at $10.0 after opening at $0.41. The day’s lowest price was $10.0 before the stock closed at $0.36.

In terms of market performance, BioAtla Inc had a fairly uneven. The highest value for the stock in the past year was $2.53 on 11/11/24, and the lowest value was recorded at $0.24 on 03/04/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

BioAtla Inc (BCAB) has experienced a quarterly rise of 6.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 23.87M and boasts a workforce of 76 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3926, with a change in price of +0.0666. Similarly, BioAtla Inc recorded 586,708 in trading volume during the last 100 days, posting a change of +19.59%.

BCAB Stock Stochastic Average

As of today, BioAtla Inc’s raw stochastic average for the last 50 days stands at 61.52%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 95.98%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 60.52% and 50.61%, respectively.

BCAB Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -77.41% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 19.55%. Over the past 30 days, the price of BCAB has fallen by 14.86%. And in the last five days, it has surged by 9.86%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.